secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2023-10-16T23:59:59+00:00
Accession:  0001493152-23-037376
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Calidi Biotherapeutics board member Dr. Heehyoung Lee resigns effective immediately
--------------------------------------------------------------------------------

- Dr. Heehyoung Lee resigned from the Board and all committees on October 10, 2023.
- Resignation is for personal reasons, not due to any disagreement with management or the Board.
- No replacement director has been announced as of the filing date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000149315223037376/0001493152-23-037376-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000149315223037376/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-037376

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer